Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

22.50
Delayed Data
As of 4:00pm ET
 +0.60 / +2.74%
Today’s Change
11.85
Today|||52-Week Range
24.90
+61.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Contact Information

Momenta Pharmaceuticals, Inc.
301 Binney Street
Cambridge Massachusetts 02142
P:(617) 491-9700
Investor Relations:
(617) 395-5189

Employees

Shareholders

Mutual fund holders58.26%
Other institutional35.05%
Individual stakeholders18.85%

Top Executives

Craig A. WheelerPresident, Chief Executive Officer & Director
Ganesh Venkataraman KaundinyaChief Operating Officer & Chief Scientific Officer
Santiago ArroyoChief Medical Officer & Senior VP-Development
Anthony M. ManningSenior Vice President-Research
Bruce A. LeicherSecretary, Senior VP & General Counsel